Highland Capital Management Fund Advisors, L.P. Mustang Bio, Inc. Transaction History

Highland Capital Management Fund Advisors, L.P.

$846 Million
Q3 2024

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Aug 16, 2021	SELL	$2.7 - $3.81 $229,500 - $323,850	-85,000 Closed	0 $0
Q3 2020 Nov 16, 2020	SELL	$3.01 - $3.88 $150,500 - $194,000	-50,000 Reduced 37.04%	85,000 $268,000
Q2 2020 Aug 14, 2020	BUY	$2.33 - $4.6 $34,950 - $69,000	15,000 Added 12.5%	135,000 $429,000
Q1 2020 May 15, 2020	SELL	$1.91 - $4.52 $420,200 - $994,399	-220,000 Reduced 64.71%	120,000 $322,000
Q4 2019 Feb 14, 2020	SELL	$2.57 - $4.08 $25,700 - $40,800	-10,000 Reduced 2.86%	340,000 $1.39 Million
Q3 2019 Nov 14, 2019	BUY	$2.74 - $4.65 $959,000 - $1.63 Million	350,000 New	350,000 $1.14 Million

Others Institutions Holding MBIO

# of Institutions

Shares Held

415K

Call Options Held

Put Options Held

View Full List

About MUSTANG BIO, INC.

Ticker MBIO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 105,222,000
Market Cap $21M
Description
Mustang Bio, Inc., a clinical-stage biopharmaceutical company, focuses on translating medical breakthroughs in cell and gene therapies into potential cures for hematologic cancers, solid tumors, and rare genetic diseases. Its pipeline focuses on gene therapy programs for rare genetic disorders, chimeric antigen receptor (CAR) engineered T cell (...

More about MBIO

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Highland Capital Management Fund Advisors, L.P., based on Form 13F filings with the SEC.

News

Stay updated on Highland Capital Management Fund Advisors, L.P. with notifications on news.

Account